High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer
ObjectivesMesothelin (MSLN) is a cell-surface glycoprotein overexpressed in the majority of pancreatic ductal adenocarcinoma (PDAC) cases and represents a promising immunotherapeutic target. Despite studies and clinical trials investigating MSLN-target…